Caseware UK (AP4) 2022.0.179 2022.0.179 2023-03-312023-03-31truefalseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.2022-01-14Holding company2false 13848715 2022-01-13 13848715 2022-01-14 2023-03-31 13848715 2021-01-14 2022-01-13 13848715 2023-03-31 13848715 c:Director1 2022-01-14 2023-03-31 13848715 d:CurrentFinancialInstruments 2023-03-31 13848715 d:Non-currentFinancialInstruments 2023-03-31 13848715 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 13848715 d:Non-currentFinancialInstruments d:AfterOneYear 2023-03-31 13848715 d:ShareCapital 2023-03-31 13848715 d:RetainedEarningsAccumulatedLosses 2023-03-31 13848715 c:FRS102 2022-01-14 2023-03-31 13848715 c:AuditExempt-NoAccountantsReport 2022-01-14 2023-03-31 13848715 c:FullAccounts 2022-01-14 2023-03-31 13848715 c:PrivateLimitedCompanyLtd 2022-01-14 2023-03-31 13848715 d:Subsidiary1 2022-01-14 2023-03-31 13848715 d:Subsidiary1 1 2022-01-14 2023-03-31 13848715 6 2022-01-14 2023-03-31 iso4217:GBP xbrli:pure

Registered number: 13848715










PATIENT CARE HOLDING LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE PERIOD ENDED 31 MARCH 2023

 
PATIENT CARE HOLDING LIMITED
REGISTERED NUMBER: 13848715

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2023

2023
Note
£

Fixed assets
  

Investments
 4 
1,853,623

  
1,853,623

Current assets
  

Debtors: amounts falling due within one year
 5 
7,966

  
7,966

Creditors: amounts falling due within one year
 6 
(742,652)

Net current (liabilities)/assets
  
 
 
(734,686)

Total assets less current liabilities
  
1,118,937

Creditors: amounts falling due after more than one year
 7 
(1,133,241)

  

Net (liabilities)/assets
  
(14,304)


Capital and reserves
  

Called up share capital 
  
100

Profit and loss account
  
(14,404)

  
(14,304)


Page 1

 
PATIENT CARE HOLDING LIMITED
REGISTERED NUMBER: 13848715
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MARCH 2023

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Mr Gilbert Kamgang Nkuitche
Director
Date: 13 October 2023

The notes on pages 3 to 5 form part of these financial statements.

Page 2

 
PATIENT CARE HOLDING LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2023

1.


General information

Patient Care Holding Limited is a private company, limited by share capital, incorporated in England and Wales under registration number 13848715. The address of the registered office is Riverside House, 1-5 Como Street, Romford, Essex, RM7 7DN.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Going concern

The financial statements have been prepared on the assumption that the company will have the continued financial support of the shareholders. The shareholders of the company have sufficient resources to finance the company as and when the need arises.
The financial statements have been prepared on a going concern basis which is dependent on the financial support of the shareholders to ensure that the company will continue in operational existence for the foreseeable future.

 
2.3

Borrowing costs

All borrowing costs are recognised in profit or loss in the period in which they are incurred.

 
2.4

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each reporting date. Gains and losses on remeasurement are recognised in the Statement of comprehensive income for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

 
2.5

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 3

 
PATIENT CARE HOLDING LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2023

2.Accounting policies (continued)

 
2.6

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.7

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the period was 2.


4.


Fixed asset investments





Investments in subsidiary company

£



Cost or valuation


Additions
1,853,623



At 31 March 2023
1,853,623





Subsidiary undertaking


The following was a subsidiary undertaking of the Company:

Name

Principal activity

Class of shares

Holding

Patient Care Limited
Community pharmacy
Ordinary
100%

Page 4

 
PATIENT CARE HOLDING LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2023

5.


Debtors

2023
£


Other debtors
7,966

7,966



6.


Creditors: Amounts falling due within one year

2023
£

Bank loan
43,155

Other creditors
100,000

Amounts owed to subsidiary company (refer to note 8)
337,129

Directors' loan account
259,068

Accruals
3,300

742,652


Bank loan is secured by a fixed and floating charge over the assets of the company and personal guarantee of the directors.


7.


Creditors: Amounts falling due after more than one year

2023
£

Bank loan
1,133,241

1,133,241


Bank loan is secured by a fixed and floating charge over the assets of the company and personal guarantee given by the directors.


8.


Controlling party

The company was under the control of Mr Gilbert Kamgang Nkuitche (50% share) and Mrs Chiara Fantuzzi (50% share) by virtue of the fact that between them they own 100% of the issued share capital of the company.

 
Page 5